These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 16982774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
    Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS.
    J Immunol; 1999 Dec 01; 163(11):6251-60. PubMed ID: 10570318
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli.
    Bechetoille N, André V, Valladeau J, Perrier E, Dezutter-Dambuyant C.
    J Leukoc Biol; 2006 Jul 01; 80(1):45-58. PubMed ID: 16614258
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 01; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G, Wu K, Tao K, Lu X, Ma J, Mao Z, Li H, Shi L, Li J, Niu Y, Xiang F, Wang G.
    Mol Med Rep; 2015 Jul 01; 12(1):760-8. PubMed ID: 25695487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ, Choi BH, Kang HK, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ.
    Leuk Res; 2008 Nov 01; 32(11):1653-60. PubMed ID: 18501426
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells.
    Ifergan I, Kébir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A.
    Brain; 2008 Mar 01; 131(Pt 3):785-99. PubMed ID: 18156156
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
    McCarter MD, Baumgartner J, Escobar GA, Richter D, Lewis K, Robinson W, Wilson C, Palmer BE, Gonzalez R.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2854-60. PubMed ID: 17593331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
    Pietra G, Mortarini R, Parmiani G, Anichini A.
    Cancer Res; 2001 Nov 15; 61(22):8218-26. PubMed ID: 11719453
    [Abstract] [Full Text] [Related]

  • 20. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
    Mueller RB, Skapenko A, Grunke M, Wendler J, Stuhlmuller B, Kalden JR, Schulze-Koops H.
    Arthritis Rheum; 2005 Feb 15; 52(2):451-60. PubMed ID: 15692975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.